Mukesh Sehdev

Mukesh Sehdev is an experienced CMC professional with a diverse background in the biopharmaceutical sector. Currently, Mukesh serves as the Head of CMC at Citryll, overseeing various activities including process development and clinical supply. As the founder and independent CMC consultant at Sehdev Biopharma Ltd, Mukesh has also held significant roles at organizations such as Akari Therapeutics, Precigen ActoBio, and Sanofi Belgium, where key projects included the successful advancement of products like Nomacopan and Caplacizumab to regulatory approvals. With an academic foundation in Pharmaceutical Medicine (MSc from the University of Surrey) and Immunology (BSc from the University of East London), Mukesh's career spans over three decades, highlighting a strong ability in CMC strategies, regulatory compliance, and vendor management in a global context.